Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors
NCT05760196
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Objective Response Rate
Interventions
DRUG:
GM-CSF
Sponsor
Xiangpan Li